The Executive Director, Oncology Drug Development & Commercialization Communications in Corporate Affairs, is responsible for the overall strategy, execution, and measurement of product, pipeline, and therapeutic area communications across BMS's oncology portfolio — spanning both Drug Development and Commercialization. This includes marketed brands, late-stage pipeline assets, new indications, and therapeutic areas including solid tumors, hematologic malignancies, and cell therapy modalities. Leading a team of communications professionals, the Executive Director will serve as the primary Corporate Affairs advisor to senior leaders across both the Global Drug Development and Oncology Commercialization organizations, as well as their associated leadership teams. This role will partner closely with commercial, medical, regulatory, legal, and development functions, and operate within and across the Corporate Affairs matrix to drive integrated internal and external communications at every stage of the product lifecycle. The Executive Director will also lead internal communications to engage and inspire employees across oncology and will develop thought leadership programs for senior executives in both the development and commercialization organizations. This leader will guide above-brand oncology communications strategy, reputational issues management, and risk mitigation globally and in the U.S., with the overarching goal of elevating BMS's position as a leader in oncology and cancer care.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive